Mutation analysis of the WT1 gene in myelodysplastic syndromes

Japanese Journal of Cancer Research

Volumn 89, Issue 8, 1998, Pages 821-824

  Hosoya, Noriko ^a   Miyagawa, Kiyoshi ^b   Mitani, Kinuko ^a   Yazaki, Yoshio ^a   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Hematological disease; Mutation; Myelodysplastic syndrome; Tumor suppressor gene; WT1

Indexed keywords

DNA; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0031693630     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00634.x     Document Type: Article

References (19)

1. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Krai, A., Yeger, H., Lewis, W. H., Jones, C. and Housman, D. E. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60, 509-520 (1990).
2. Gessler, M., Poustka, A., Cavenee, W., Neve, R. L., Orkin, S. H. and Bruns, G. A. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774-778 (1990).
3. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M. and Housman, D. E. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl. Acad. Sci. USA, 88, 9618-9622 (1991).
4. Rauscher, F. J., III The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J., 7, 896-903 (1993).
5. Miyagawa, K., Kent, J., Moore, A., Charlieu, J. P., Little, M. H., Williamson, K. A., Kelsey, A., Brown, K. W., Hassam, S., Briner, J., Hayashi, Y., Hirai, H., Yazaki, Y., van Heyningen, V. and Hastie, N. D. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour. Nat. Genet., 18, 15-17 (1998).
6. Little, M. and Wells, C. A clinical overview of WT1 gene mutations. Hum. Mutat., 9, 209-225 (1997).
7. Pritchard-Jones, K., Renshaw, J. and King-Underwood, L. The Wilms' tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient. Hum. Mol. Genet., 3, 1633-1637 (1994).
8. King-Underwood, L., Renshaw, J. and Pritchard-Jones, K. Mutations in the Wilms' tumor gene WT1 in leukemias. Blood, 87, 2171-2179 (1996).
9. King-Underwood, L. and Pritchard-Jones, K. Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood, 91, 2961-2968 (1998).
10. Maurer, U., Brieger, J., Weidmann, E., Mitrou, P. S., Hoezler, D. and Bergmann, L. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in course of differentiation in vitro. Exp. Hematol., 25, 945-950 (1997).
11. Miwa, H., Beran, M. and Saunders, G. F. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia, 6, 405-409 (1992).
12. Miyagi, T., Ahuja, H., Kubota, T., Kubonishi, I., Koeffler, H. P. and Miyoshi, I. Expression of the candidate Wilms' tumor gene, WT1, in human leukemia cells. Leukemia, 7, 970-977 (1993).
13. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Kyo, T., Dohy, H., Nakauchi, H., Ishidate, T., Akiyama, T. and Kishimoto, T. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84, 3071-3079 (1994).
14. Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E. and Hoelzer, D. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood, 90, 1217-1225 (1997).
15. Phelan, S. A., Lindberg, C. and Call, K.M. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ., 5, 677-686 (1994).
16. Sekiya, M., Adachi, M., Hinoda, Y., Imai, K. and Yachi, A. Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood, 83, 1876-1882 (1994).
17. Maheswaran, S., Englert, C., Bennett, P., Heinrich, G. and Haber, D. A. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev., 9, 2143-2156 (1995).
18. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayashi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y., Ueda, R. and Hirai, H. Loss of the cyclin-dependent kinase 4-inhibitor(p16;MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 86, 1548-1556 (1995).
19. Groves, N., Baird, P. N., Hogg, A. and Cowell, J. K. A single base pair polymorphism in the WT1 gene detected by single-strand conformation polymorphism analysis. Hum. Genet., 90, 440-442 (1992).